Cumberland Pharmaceuticals appoints Carr, Riggs & Ingram as new independent auditor for FY 2023

CUMBERLAND PHARMACEUTICALS INC

Appointed CRI as independent registered public accounting firm for FY ending Dec 31, 2023, effective for interim period ending June 30, 2023.
No prior consultations with CRI on accounting principles or audit opinion type.
No disagreements or reportable events between the company and predecessor auditor as defined in Regulation S-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.